Karyopharm Therapeutics Inc. (KPTI) Free cash flow 2016–2025
Karyopharm Therapeutics Inc. (KPTI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$75.4MFY2025 · since FY2016: -$84.5M → -$75.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$75.4M | +40.9% |
| FY2024 | -$127.6M | -37.6% |
| FY2023 | -$92.7M | +38.0% |
| FY2022 | -$149.7M | -39.5% |
| FY2021 | -$107.3M | +33.1% |
| FY2020 | -$160.4M | +16.0% |
| FY2019 | -$191.0M | -18.3% |
| FY2018 | -$161.5M | -118.9% |
| FY2017 | -$73.8M | +12.6% |
| FY2016 | -$84.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice